Glenn M. Chertow

Nephrologist - Kidney specialist

Dialysis specialist, Acute kidney disease specialist, Chronic kidney disease specialist

Kidney Clinic (Nephrology)

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-723-6961
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Fellowship: Brigham and Women's Hospital Harvard Medical School (1995) MA

Residency: Brigham and Women's Hospital Harvard Medical School (1992) MA

Board Certification: Nephrology, American Board of Internal Medicine (1994)

Medical Education: Harvard Medical School (1989) MA

MPH, Harvard School of Public Health, Epidemiology and Biostatistics (1995)

MD, Harvard Medical School, Medicine (1989)

BA, University of Pennsylvania (1985)

Honors & Awards

Senior Mentor, Network of Minority Research Investigators, NIDDK (2008)

Mentor of the Year, Bay Area Clinical Research Symposium (2007)

National Torchbearer Award, American Kidney Fund (2007)

STAR Award, UCSF Medical Center (2006)

Inductee, Society of Master Clinicians, UCSF Department of Medicine (2006)

Nominee, Kaiser Awards for Excellence in Teaching, UCSF School of Medicine (2005)

Member, American Society of Clinical Investigation (2004)

"Top Doctors in Bay Area” designation, San Francisco Magazine Inductee, American Society of Clinical Investigation (2002-2004)

Nominee, Kaiser Awards for Excellence in Teaching, UCSF School of Medicine (2002)

Academic Senate Distinction in Teaching Award Honorable Mention, USCF School of Medicine (2002)

Floyd C. Rector, Jr., Housestaff Teaching Award, Department of Medicine, UCSF (2001)

President’s Award, National Kidney Foundation (1999)

“Top Doctors in Bay Area” designation, San Francisco Magazine (1999-2000)

“Best Doctors in Boston” designation, Boston Magazine (1997-98)

“Best Doctors in America” designation, Woodward and White (1996)

Calvin and Sylvia Margolis Scholar in Internal Medicine, Department of Medicine, BWH (1996-97)

American Kidney Fund, Amgen Clinical Scientist in Nephrology (1993-95)

Hewlett Packard Outstanding Medical Graduate Award, HMS (1989)

Phi Beta Kappa, University of Pennsylvania (1985)

Summa Cum Laude, University of Pennsylvania (1985)

Administrative Appointments

Clinical Fellow in Medicine, Harvard Medical School, Boston, MA (HMS), 1989

Research Fellow in Medicine, HMS, 1992

Instructor in Medicine, HMS, 1995

Instructor in Surgery, HMS, 1966

Assistant Professor of Medicine, HMS, 1997

Assistant Professor of Medicine in Residence, University of California San Francisco School of Medicine, San Francisco, CA (UCSF), 1998

Associate Professor of Medicine in Residence, UCSF, 2001

Associate Professor of Epidemiology and Biostatistics, UCSF, 2004

Professor of Medicine in Residence, UCSF, 2005

Professor of Epidemiology and Biostatistics, UCSF, 2005

Professor of Medicine, Stanford University School of Medicine, 2007

Associate, Center for Health Policy, Center for Primary Care and Outcomes Research, Stanford University, 2008

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Hospital & Clinics patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Diabetic Severity and Risk of Kidney Stone Disease
Weinberg, A. E., Patel, C. J., Chertow, G. M., & Leppert, J. T. (2014). Diabetic Severity and Risk of Kidney Stone Disease. EUROPEAN UROLOGY, 65(1), 242-247.

Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial.
Lambers Heerspink, H. J., Chertow, G. M., Akizawa, T., Audhya, P., Bakris, G. L., & de Zeeuw, D. (2013). Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 28(11), 2841-2850.

Vitamin D Deficiency and Mortality in Patients Receiving Dialysis: The Comprehensive Dialysis Study
Anand, S., Chertow, G. M., Johansen, K. L., Grimes, B., Dalrymple, L. S., & Tamura, M. K. (2013). Vitamin D Deficiency and Mortality in Patients Receiving Dialysis: The Comprehensive Dialysis Study. JOURNAL OF RENAL NUTRITION, 23(6), 422-427.

Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease.
Erickson, K. F., Chertow, G. M., & Goldhaber-Fiebert, J. D. (2013). Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Annals of internal medicine, 159(6), 382-389.

Temporal Trends in the Incidence, Treatment, and Outcomes of Hip Fracture in Older Patients Initiating Dialysis in the United States
Nair, S. S., Mitani, A. A., Goldstein, B. A., Chertow, G. M., Lowenberg, D. W., & Winkelmayer, W. C. (2013). Temporal Trends in the Incidence, Treatment, and Outcomes of Hip Fracture in Older Patients Initiating Dialysis in the United States. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 8(8), 1336-1342.

Variation in Nephrologist Visits to Patients on Hemodialysis across Dialysis Facilities and Geographic Locations.
Erickson, K. F., Tan, K. B., Winkelmayer, W. C., Chertow, G. M., & Bhattacharya, J. (2013). Variation in Nephrologist Visits to Patients on Hemodialysis across Dialysis Facilities and Geographic Locations. Clinical journal of the American Society of Nephrology , 8(6), 987-994.

Cinacalcet for cardiovascular disease in patients undergoing dialysis.
Chertow, G. M., & Parfrey, P. S. (2013). Cinacalcet for cardiovascular disease in patients undergoing dialysis. New England journal of medicine, 368(19), 1844-1845.

Effect of frequent hemodialysis on residual kidney function.
Daugirdas, J. T., Greene, T., Rocco, M. V., Kaysen, G. A., Depner, T. A., & Kliger, A. S. (2013). Effect of frequent hemodialysis on residual kidney function. Kidney international, 83(5), 949-958.

Effects of 6-Times-Weekly Versus 3-Times-Weekly Hemodialysis on Depressive Symptoms and Self-reported Mental Health: Frequent Hemodialysis Network (FHN) Trials
Unruh, M. L., Larive, B., Chertow, G. M., Eggers, P. W., Garg, A. X., & Kimmel, P. L. (2013). Effects of 6-Times-Weekly Versus 3-Times-Weekly Hemodialysis on Depressive Symptoms and Self-reported Mental Health: Frequent Hemodialysis Network (FHN) Trials. AMERICAN JOURNAL OF KIDNEY DISEASES, 61(5), 748-758.

Cost-Effectiveness of Statins for Primary Cardiovascular Prevention in Chronic Kidney Disease
Erickson, K. F., Japa, S., Owens, D. K., Chertow, G. M., Garber, A. M., & Goldhaber-Fiebert, J. D. (2013). Cost-Effectiveness of Statins for Primary Cardiovascular Prevention in Chronic Kidney Disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 61(12), 1250-1258.

Longitudinal Measures of Serum Albumin and Prealbumin Concentrations in Incident Dialysis Patients: The Comprehensive Dialysis Study
Dalrymple, L. S., Johansen, K. L., Chertow, G. M., Grimes, B., Anand, S., & Kaysen, G. A. (2013). Longitudinal Measures of Serum Albumin and Prealbumin Concentrations in Incident Dialysis Patients: The Comprehensive Dialysis Study. JOURNAL OF RENAL NUTRITION, 23(2), 91-97.

Association of Physical Activity with Survival among Ambulatory Patients on Dialysis: The Comprehensive Dialysis Study
Johansen, K. L., Kaysen, G. A., Dalrymple, L. S., Grimes, B. A., Glidden, D. V., & Chertow, G. M. (2013). Association of Physical Activity with Survival among Ambulatory Patients on Dialysis: The Comprehensive Dialysis Study. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 8(2), 248-253.

Prevention of Contrast-Induced AKI: A Review of Published Trials and the Design of the Prevention of Serious Adverse Events following Angiography (PRESERVE) Trial.
Weisbord, S. D., Gallagher, M., Kaufman, J., Cass, A., Parikh, C. R., & Palevsky, P. M. (2013). Prevention of Contrast-Induced AKI: A Review of Published Trials and the Design of the Prevention of Serious Adverse Events following Angiography (PRESERVE) Trial. Clinical journal of the American Society of Nephrology : CJASN.

Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008.
Lenihan, C. R., Montez-Rath, M. E., Mora Mangano, C. T., Chertow, G. M., & Winkelmayer, W. C. (2013). Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008. Annals of thoracic surgery, 95(1), 20-28.

Physical activity and self-reported symptoms of insomnia, restless legs syndrome, and depression: The comprehensive dialysis study
Anand, S., Johansen, K. L., Grimes, B., Kaysen, G. A., Dalrymple, L. S., & Chertow, G. M. (2013). Physical activity and self-reported symptoms of insomnia, restless legs syndrome, and depression: The comprehensive dialysis study. HEMODIALYSIS INTERNATIONAL, 17(1), 50-58.

Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study.
Yang, J.-Y., Lee, T.-C., Montez-Rath, M. E., Chertow, G. M., & Winkelmayer, W. C. (2013). Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study. BMC nephrology, 14, 97-?.

A Transcriptional Blueprint for Human and Murine Diabetic Kidney Disease
Bhalla, V., Velez, M.-G., & Chertow, G. M. (2013). A Transcriptional Blueprint for Human and Murine Diabetic Kidney Disease. DIABETES, 62(1), 31-33.

Oh! What a Tangled Web We Weave.
Arora, N., & Chertow, G. M. (2013). Oh! What a Tangled Web We Weave. Clinical journal of the American Society of Nephrology : CJASN.

Piecewise Analysis of Patient Survival after Onset of AKI.
Zhang, J. H., Palevsky, P. M., Chertow, G. M., Hartigan, J., O'Connor, T. Z., & Zhou, B. (2013). Piecewise Analysis of Patient Survival after Onset of AKI. Clinical journal of the American Society of Nephrology : CJASN.

Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis.
Chang, T. I., Flythe, J. E., Brunelli, S. M., Muntner, P., Greene, T., & Chertow, G. M. (2013). Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis. Journal of human hypertension.

Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON)
de Zeeuw, D., Akizawa, T., Agarwal, R., Audhya, P., Bakrise, G. L., & Chertow, G. M. (2013). Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON). AMERICAN JOURNAL OF NEPHROLOGY, 37(3), 212-222.

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
Chertow, G. M., Block, G. A., Correa-Rotter, R., Drüeke, T. B., Floege, J., & Parfrey, P. S. (2012). Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. New England journal of medicine, 367(26), 2482-2494.

Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis
Chertow, G. M., Block, G. A., Correa-Rotter, R., Drueeke, T. B., Floege, J., & Parfrey, P. S. (2012). Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis. NEW ENGLAND JOURNAL OF MEDICINE, 367(26), 2482-2494.

Venous Thromboembolism Yet Another Cardiovascular Complication of Chronic Kidney Disease?
Chertow, G. M., & Mahaffey, K. W. (2012). Venous Thromboembolism Yet Another Cardiovascular Complication of Chronic Kidney Disease?. CIRCULATION, 126(16), 1937-1938.

Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney
Reisman, S. A., Chertow, G. M., Hebbar, S., Vaziri, N. D., Ward, K. W., & Meyer, C. J. (2012). Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 23(10), 1663-1673.

Individualized reduction in dialysate sodium in conventional in-center hemodialysis
Arramreddy, R., Sun, S. J., Mendoza, J. M., Chertow, G. M., & Schiller, B. (2012). Individualized reduction in dialysate sodium in conventional in-center hemodialysis. HEMODIALYSIS INTERNATIONAL, 16(4), 473-480.

Donor Recipient Sex Mismatch in Kidney Transplantation
Tan, J. C., Kim, J. P., Chertow, G. M., Grumet, F. C., & Desai, M. (2012). Donor Recipient Sex Mismatch in Kidney Transplantation. GENDER MEDICINE, 9(5), 335-347.

Effects of Phosphate Binders in Moderate CKD
Block, G. A., Wheeler, D. C., Persky, M. S., Kestenbaum, B., Ketteler, M., & Chertow, G. M. (2012). Effects of Phosphate Binders in Moderate CKD. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 23(8), 1407-1415.

Frailty, Dialysis Initiation, and Mortality in End-Stage Renal Disease
Bao, Y., Dalrymple, L., Chertow, G. M., Kaysen, G. A., & Johansen, K. L. (2012). Frailty, Dialysis Initiation, and Mortality in End-Stage Renal Disease. ARCHIVES OF INTERNAL MEDICINE, 172(14), 1071-1077.

Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial
Chertow, G. M., Correa-Rotter, R., Block, G. A., Drueke, T. B., Floege, J., & Parfrey, P. S. (2012). Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial. NEPHROLOGY DIALYSIS TRANSPLANTATION, 27(7), 2872-2879.

Homelessness and CKD: A Cohort Study
Hall, Y. N., Choi, A. I., Himmelfarb, J., Chertow, G. M., & Bindman, A. B. (2012). Homelessness and CKD: A Cohort Study. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(7), 1094-1102.

The effect of frequent hemodialysis on nutrition and body composition: Frequent Hemodialysis Network Trial
Kaysen, G. A., Greene, T., Larive, B., Mehta, R. L., Lindsay, R. M., & Chertow, G. M. (2012). The effect of frequent hemodialysis on nutrition and body composition: Frequent Hemodialysis Network Trial. KIDNEY INTERNATIONAL, 82(1), 90-99.

Validation of Reported Predialysis Nephrology Care of Older Patients Initiating Dialysis
Kim, J. P., Desai, M., Chertow, G. M., & Winkelmayer, W. C. (2012). Validation of Reported Predialysis Nephrology Care of Older Patients Initiating Dialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 23(6), 1078-1085.

Toward the optimal dose metric in continuous renal replacement therapy
Claure-Del Granado, R., Macedo, E., Chertow, G. M., Soroko, S., Himmelfarb, J., & Mehta, R. L. (2012). Toward the optimal dose metric in continuous renal replacement therapy. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 35(6), 413-424.

Design of Clinical Trials in Acute Kidney Injury: A Report from an NIDDK Workshop-Prevention Trials
Okusa, M. D., Molitoris, B. A., Palevsky, P. M., Chinchilli, V. M., Liu, K. D., & Star, R. A. (2012). Design of Clinical Trials in Acute Kidney Injury: A Report from an NIDDK Workshop-Prevention Trials. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(5), 851-855.

Design of Clinical Trials in AKI: A Report from an NIDDK Workshop. Trials of Patients with Sepsis and in Selected Hospital Settings
Molitoris, B. A., Okusa, M. D., Palevsky, P. M., Chawla, L. S., Kaufman, J. S., & Star, R. A. (2012). Design of Clinical Trials in AKI: A Report from an NIDDK Workshop. Trials of Patients with Sepsis and in Selected Hospital Settings. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(5), 856-860.

Challenges to enrollment and randomization of the frequent hemodialysis network (FHN) daily trial
Sergeyeva, O., Gorodetskaya, I., Ramos, R., Schiller, B. M., Larive, B., & Levin, N. W. (2012). Challenges to enrollment and randomization of the frequent hemodialysis network (FHN) daily trial. JOURNAL OF NEPHROLOGY, 25(3), 302-309.

Design of Clinical Trials in Acute Kidney Injury: Report from an NIDDK Workshop on Trial Methodology
Palevsky, P. M., Molitoris, B. A., Okusa, M. D., Levin, A., Waikar, S. S., & Star, R. A. (2012). Design of Clinical Trials in Acute Kidney Injury: Report from an NIDDK Workshop on Trial Methodology. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(5), 844-850.

Ongoing Clinical Trials in AKI
Faubel, S., Chawla, L. S., Chertow, G. M., Goldstein, S. L., Jaber, B. L., & Liu, K. D. (2012). Ongoing Clinical Trials in AKI. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(5), 861-873.

Effects of Six versus Three Times per Week Hemodialysis on Physical Performance, Health, and Functioning: Frequent Hemodialysis Network (FHN) Randomized Trials
Hall, Y. N., Larive, B., Painter, P., Kaysen, G. A., Lindsay, R. M., & Chertow, G. M. (2012). Effects of Six versus Three Times per Week Hemodialysis on Physical Performance, Health, and Functioning: Frequent Hemodialysis Network (FHN) Randomized Trials. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(5), 782-794.

Effects of Frequent Hemodialysis on Measures of CKD Mineral and Bone Disorder
Daugirdas, J. T., Chertow, G. M., Larive, B., Pierratos, A., Greene, T., & Kliger, A. S. (2012). Effects of Frequent Hemodialysis on Measures of CKD Mineral and Bone Disorder. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 23(4), 727-738.

Self-reported symptoms in patients on hemodialysis with moderate to severe secondary hyperparathyroidism receiving combined therapy with cinacalcet and low-dose vitamin D sterols
Chertow, G. M., Lu, Z. J., Xu, X., Knight, T. G., Goodman, W. G., & Block, G. A. (2012). Self-reported symptoms in patients on hemodialysis with moderate to severe secondary hyperparathyroidism receiving combined therapy with cinacalcet and low-dose vitamin D sterols. HEMODIALYSIS INTERNATIONAL, 16(2), 188-197.

Trends in Acute Nonvariceal Upper Gastrointestinal Bleeding in Dialysis Patients
Yang, J.-Y., Lee, T.-C., Montez-Rath, M. E., Paik, J., Chertow, G. M., & Winkelmayer, W. C. (2012). Trends in Acute Nonvariceal Upper Gastrointestinal Bleeding in Dialysis Patients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 23(3), 495-506.

Determinants of Left Ventricular Mass in Patients on Hemodialysis Frequent Hemodialysis Network (FHN) Trials
Chan, C. T., Greene, T., Chertow, G. M., Kliger, A. S., Stokes, J. B., & Rajagopalan, S. (2012). Determinants of Left Ventricular Mass in Patients on Hemodialysis Frequent Hemodialysis Network (FHN) Trials. CIRCULATION-CARDIOVASCULAR IMAGING, 5(2), 251-261.

Prospective Safety Study of Bardoxolone Methyl in Patients with Type 2 Diabetes Mellitus, End-Stage Renal Disease and Peritoneal Dialysis
Warnock, D. G., Hebbar, S., Bargman, J., Burkart, J., Davies, S., & Chertow, G. M. (2012). Prospective Safety Study of Bardoxolone Methyl in Patients with Type 2 Diabetes Mellitus, End-Stage Renal Disease and Peritoneal Dialysis. PERITONEAL DIALYSIS - STATE-OF-THE-ART 2012, 178, 157-163.

Acute Kidney Injury and Mortality in Hospitalized Patients
Wang, H. E., Muntner, P., Chertow, G. M., & Warnock, D. G. (2012). Acute Kidney Injury and Mortality in Hospitalized Patients. AMERICAN JOURNAL OF NEPHROLOGY, 35(4), 349-355.

Validity of Surrogate Measures for Functional Nephron Mass
Tan, J. C., Paik, J., Chertow, G. M., Grumet, F. C., Busque, S., & Desai, M. (2011). Validity of Surrogate Measures for Functional Nephron Mass. TRANSPLANTATION, 92(12), 1335-1341.

Vitamin D deficiency, self-reported physical activity and health-related quality of life: the Comprehensive Dialysis Study
Anand, S., Kaysen, G. A., Chertow, G. M., Johansen, K. L., Grimes, B., & Tamura, M. K. (2011). Vitamin D deficiency, self-reported physical activity and health-related quality of life: the Comprehensive Dialysis Study. NEPHROLOGY DIALYSIS TRANSPLANTATION, 26(11), 3683-3688.

Association of Self-reported Physical Activity With Laboratory Markers of Nutrition and Inflammation: The Comprehensive Dialysis Study
Anand, S., Chertow, G. M., Johansen, K. L., Grimes, B., Tamura, M. K., & Kaysen, G. A. (2011). Association of Self-reported Physical Activity With Laboratory Markers of Nutrition and Inflammation: The Comprehensive Dialysis Study. JOURNAL OF RENAL NUTRITION, 21(6), 429-437.

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial
Rocco, M. V., Lockridge, R. S., Beck, G. J., Eggers, P. W., Gassman, J. J., & Kliger, A. S. (2011). The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. KIDNEY INTERNATIONAL, 80(10), 1080-1091.

Chronic Kidney Disease and Cardiovascular Therapeutics Time to Close the Evidence Gaps
Chang, T. I., & Chertow, G. M. (2011). Chronic Kidney Disease and Cardiovascular Therapeutics Time to Close the Evidence Gaps. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 58(11), 1162-1164.

Living donor evaluation and exclusion: the Stanford experience
Lapasia, J. B., Kong, S.- yee, Busque, S., Scandling, J. D., Chertow, G. M., & Tan, J. C. (2011). Living donor evaluation and exclusion: the Stanford experience. CLINICAL TRANSPLANTATION, 25(5), 697-704.

Model to Predict Mortality in Critically Ill Adults with Acute Kidney Injury
Demirjian, S., Chertow, G. M., Zhang, J. H., O'Connor, T. Z., Vitale, J., & Palevsky, P. M. (2011). Model to Predict Mortality in Critically Ill Adults with Acute Kidney Injury. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(9), 2114-2120.

Predialysis Nephrology Care of Older Patients Approaching End-stage Renal Disease
Winkelmayer, W. C., Liu, J., Chertow, G. M., & Tamura, M. K. (2011). Predialysis Nephrology Care of Older Patients Approaching End-stage Renal Disease. ARCHIVES OF INTERNAL MEDICINE, 171(15), 1371-1378.

Assessment and management of vascular disease risk in patients with chronic kidney disease
Brown, W. V., Bakris, G., Lerma, E., & Chertow, G. (2011). Assessment and management of vascular disease risk in patients with chronic kidney disease. JOURNAL OF CLINICAL LIPIDOLOGY, 5(4), 251-260.

Intradialytic Hypotension and Vascular Access Thrombosis
Chang, T. I., Paik, J., Greene, T., Desai, M., Bech, F., & Chertow, G. M. (2011). Intradialytic Hypotension and Vascular Access Thrombosis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 22(8), 1526-1533.

Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis
Chang, T. I., Shilane, D., Brunelli, S. M., Cheung, A. K., Chertow, G. M., & Winkelmayer, W. C. (2011). Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis. AMERICAN HEART JOURNAL, 162(2), 324-330.

Burden on caregivers as perceived by hemodialysis patients in the Frequent Hemodialysis Network (FHN) trials
Suri, R. S., Larive, B., Garg, A. X., Hall, Y. N., Pierratos, A., & Kliger, A. S. (2011). Burden on caregivers as perceived by hemodialysis patients in the Frequent Hemodialysis Network (FHN) trials. NEPHROLOGY DIALYSIS TRANSPLANTATION, 26(7), 2316-2322.

Risk of Cardiovascular Events after Infection-Related Hospitalizations in Older Patients on Dialysis
Dalrymple, L. S., Mohammed, S. M., Mu, Y., Johansen, K. L., Chertow, G. M., & Nguyen, D. V. (2011). Risk of Cardiovascular Events after Infection-Related Hospitalizations in Older Patients on Dialysis. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(7), 1708-1713.

Incidence, Correlates, and Consequences of Acute Kidney Injury in Patients With Pulmonary Arterial Hypertension Hospitalized With Acute Right-Side Heart Failure
Haddad, F., Fuh, E., Peterson, T., Skhiri, M., Kudelko, K. T., & Zamanian, R. T. (2011). Incidence, Correlates, and Consequences of Acute Kidney Injury in Patients With Pulmonary Arterial Hypertension Hospitalized With Acute Right-Side Heart Failure. JOURNAL OF CARDIAC FAILURE, 17(7), 533-539.

Update in Nephrology: Evidence Published in 2010
Arora, N., & Chertow, G. M. (2011). Update in Nephrology: Evidence Published in 2010. ANNALS OF INTERNAL MEDICINE, 154(12), 824-U79.

Modeled Urea Distribution Volume and Mortality in the HEMO Study
Daugirdas, J. T., Greene, T., Depner, T. A., Levin, N. W., & Chertow, G. M. (2011). Modeled Urea Distribution Volume and Mortality in the HEMO Study. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(5), 1129-1138.

Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach?
Munoz Mendoza, J., Sun, S., Chertow, G. M., Moran, J., Doss, S., & Schiller, B. (2011). Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach?. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 26(4), 1281-1287.

The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis
Raggi, P., Chertow, G. M., Torres, P. U., Csiky, B., Naso, A., & Floege, J. (2011). The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. NEPHROLOGY DIALYSIS TRANSPLANTATION, 26(4), 1327-1339.

Racial Ethnic Differences in Rates and Determinants of Deceased Donor Kidney Transplantation
Hall, Y. N., Choi, A. I., Xu, P., O'Hare, A. M., & Chertow, G. M. (2011). Racial Ethnic Differences in Rates and Determinants of Deceased Donor Kidney Transplantation. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 22(4), 743-751.

Aspirin and Arteriovenous Graft Thrombosis in Hemodialysis: Just What the Doctor Ordered?
Bech, F. R., & Chertow, G. M. (2011). Aspirin and Arteriovenous Graft Thrombosis in Hemodialysis: Just What the Doctor Ordered?. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 22(4), 595-597.

The 2011 ESRD Prospective Payment System: An Uncontrolled Experiment
Winkelmayer, W. C., & Chertow, G. M. (2011). The 2011 ESRD Prospective Payment System: An Uncontrolled Experiment. AMERICAN JOURNAL OF KIDNEY DISEASES, 57(4), 542-546.

Effluent Volume in Continuous Renal Replacement Therapy Overestimates the Delivered Dose of Dialysis
Claure-Del Gramdo, R., Macedo, E., Chertow, G. M., Soroko, S., Himmelfarb, J., & Mehta, R. L. (2011). Effluent Volume in Continuous Renal Replacement Therapy Overestimates the Delivered Dose of Dialysis. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(3), 467-475.

World Kidney Day 2011
Hostetter, T. H., Kochis, D. J., Shaffer, R. N., Chertow, G., Harmon, W. E., & Winkelmayer, W. C. (2011). World Kidney Day 2011. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 22(3), 397-398.

Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease
Mehta, R. L., Bouchard, J., Soroko, S. B., Ikizler, T. A., Paganini, E. P., & Himmelfarb, J. (2011). Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. INTENSIVE CARE MEDICINE, 37(2), 241-248.

Vascular Risk Factors and Cognitive Impairment in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study
Tamura, M. K., Xie, D., Yaffe, K., Cohen, D. L., Teal, V., & Go, A. S. (2011). Vascular Risk Factors and Cognitive Impairment in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(2), 248-256.

Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study
Chang, T. I., Friedman, G. D., Cheung, A. K., Greene, T., Desai, M., & Chertow, G. M. (2011). Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study. JOURNAL OF HUMAN HYPERTENSION, 25(2), 98-105.

Baseline Characteristics of Participants in the Frequent Hemodialysis Network (FHN) Daily and Nocturnal Trials
Rocco, M. V., Larive, B., Eggers, P. W., Beck, G. J., Chertow, G. M., & Kliger, A. S. (2011). Baseline Characteristics of Participants in the Frequent Hemodialysis Network (FHN) Daily and Nocturnal Trials. AMERICAN JOURNAL OF KIDNEY DISEASES, 57(1), 90-100.

The Phosphate Binder Equivalent Dose
Daugirdas, J. T., Finn, W. F., Emmett, M., & Chertow, G. M. (2011). The Phosphate Binder Equivalent Dose. SEMINARS IN DIALYSIS, 24(1), 41-49.

RELATIONSHIP OF BODY SIZE AND MORTALITY AMONG US ASIANS AND PACIFIC ISLANDERS ON DIALYSIS
Hall, Y. N., Xu, P., & Chertow, G. M. (2011). RELATIONSHIP OF BODY SIZE AND MORTALITY AMONG US ASIANS AND PACIFIC ISLANDERS ON DIALYSIS. ETHNICITY & DISEASE, 21(1), 40-46.

Baseline Physical Performance, Health, and Functioning of Participants in the Frequent Hemodialysis Network (FHN) Trial
Kaysen, G. A., Larive, B., Painter, P., Craig, A., Lindsay, R. M., & Chertow, G. M. (2011). Baseline Physical Performance, Health, and Functioning of Participants in the Frequent Hemodialysis Network (FHN) Trial. AMERICAN JOURNAL OF KIDNEY DISEASES, 57(1), 101-112.

End-stage Renal Disease.
Abbasi, M., Chertow, G., & Hall, Y. (2010). End-stage Renal Disease. American family physician, 82(12), 1512-?.

In-Center Hemodialysis Six Times per Week versus Three Times per Week
Chertow, G. M., Levin, N. W., Beck, G. J., Depner, T. A., Eggers, P. W., & Kliger, A. S. (2010). In-Center Hemodialysis Six Times per Week versus Three Times per Week. NEW ENGLAND JOURNAL OF MEDICINE, 363(24), 2287-2300.

Low level of self-reported physical activity in ambulatory patients new to dialysis
Johansen, K. L., Chertow, G. M., Kutner, N. G., Dalrymple, L. S., Grimes, B. A., & Kaysen, G. A. (2010). Low level of self-reported physical activity in ambulatory patients new to dialysis. KIDNEY INTERNATIONAL, 78(11), 1164-1170.

Blood Pressure Control in Type 2 Diabetes Mellitus
Chang, T. I., Cheung, A. K., & Chertow, G. M. (2010). Blood Pressure Control in Type 2 Diabetes Mellitus. AMERICAN JOURNAL OF KIDNEY DISEASES, 56(6), 1029-1031.

Curbing the Use of Ultrasonography in the Diagnosis of Acute Kidney Injury Penny Wise or Pound Foolish?
Liu, K. D., & Chertow, G. M. (2010). Curbing the Use of Ultrasonography in the Diagnosis of Acute Kidney Injury Penny Wise or Pound Foolish?. ARCHIVES OF INTERNAL MEDICINE, 170(21), 1907-1908.

Off-Label Use of Phosphate Binders in Non-Dialysis-Dependent CKD
Winkelmayer, W. C., & Chertow, G. M. (2010). Off-Label Use of Phosphate Binders in Non-Dialysis-Dependent CKD. AMERICAN JOURNAL OF KIDNEY DISEASES, 56(5), 813-816.

Determinants of Cardiac Autonomic Dysfunction in ESRD
Chan, C. T., Levin, N. W., Chertow, G. M., Lariye, B., Schulman, G., & Kotanko, P. (2010). Determinants of Cardiac Autonomic Dysfunction in ESRD. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 5(10), 1821-1827.

Updated comorbidity assessments and outcomes in prevalent hemodialysis patients
Chang, T. I., Paik, J., Greene, T., Miskulin, D. C., & Chertow, G. M. (2010). Updated comorbidity assessments and outcomes in prevalent hemodialysis patients. HEMODIALYSIS INTERNATIONAL, 14(4), 478-485.

Can Rescaling Dose of Dialysis to Body Surface Area in the HEMO Study Explain the Different Responses to Dose in Women versus Men?
Daugirdas, J. T., Greene, T., Chertow, G. M., & Depner, T. A. (2010). Can Rescaling Dose of Dialysis to Body Surface Area in the HEMO Study Explain the Different Responses to Dose in Women versus Men?. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 5(9), 1628-1636.

On the relative safety of intravenous iron formulations: New answers, new questions
Chertow, G. M., & Winkelmayer, W. C. (2010). On the relative safety of intravenous iron formulations: New answers, new questions. AMERICAN JOURNAL OF HEMATOLOGY, 85(9), 643-644.

Infection-Related Hospitalizations in Older Patients With ESRD
Dalrymple, L. S., Johansen, K. L., Chertow, G. M., Cheng, S.-C., Grimes, B., & Kaysen, G. A. (2010). Infection-Related Hospitalizations in Older Patients With ESRD. AMERICAN JOURNAL OF KIDNEY DISEASES, 56(3), 522-530.

Prevalence and Correlates of Cognitive Impairment in Hemodialysis Patients: The Frequent Hemodialysis Network Trials
Tamura, M. K., Larive, B., Unruh, M. L., Stokes, J. B., Nissenson, A., & Chertow, G. M. (2010). Prevalence and Correlates of Cognitive Impairment in Hemodialysis Patients: The Frequent Hemodialysis Network Trials. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 5(8), 1429-1438.

Vitamin D deficiency and frailty in older Americans
Wilhelm-Leen, E. R., Hall, Y. N., DEBOER, I. H., & Chertow, G. M. (2010). Vitamin D deficiency and frailty in older Americans. JOURNAL OF INTERNAL MEDICINE, 268(2), 171-180.

Reexploring Differences among For-Profit and Nonprofit Dialysis Providers
Lee, D. Kk., Chertow, G. M., & Zenios, S. A. (2010). Reexploring Differences among For-Profit and Nonprofit Dialysis Providers. HEALTH SERVICES RESEARCH, 45(3), 633-646.

Study design and subject baseline characteristics in the ADVANCE study: effects of cinacalcet on vascular calcification in haemodialysis patients
Floege, J., Raggi, P., Block, G. A., Torres, P. U., Csiky, B., & Chertow, G. M. (2010). Study design and subject baseline characteristics in the ADVANCE study: effects of cinacalcet on vascular calcification in haemodialysis patients. NEPHROLOGY DIALYSIS TRANSPLANTATION, 25(6), 1916-1923.

Kidney Disease, Hospitalized Hypertension, and Cardiovascular Events: Cause or Consequence?
Chertow, G. M., & Chang, T. I. (2010). Kidney Disease, Hospitalized Hypertension, and Cardiovascular Events: Cause or Consequence?. CIRCULATION, 121(20), 2160-2161.

Chronic Kidney Disease in the Urban Poor
Hall, Y. N., Choi, A. I., Chertow, G. M., & Bindman, A. B. (2010). Chronic Kidney Disease in the Urban Poor. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 5(5), 828-835.

Weekend Hospital Admission, Acute Kidney Injury, and Mortality
James, M. T., Wald, R., Bell, C. M., Tonelli, M., Hemmelgarn, B. R., & Chertow, G. M. (2010). Weekend Hospital Admission, Acute Kidney Injury, and Mortality. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 21(5), 845-851.

Standard Kt/V-urea: a method of calculation that includes effects of fluid removal and residual kidney clearance
Daugirdas, J. T., Depner, T. A., Greene, T., Levin, N. W., Chertow, G. M., & Rocco, M. V. (2010). Standard Kt/V-urea: a method of calculation that includes effects of fluid removal and residual kidney clearance. KIDNEY INTERNATIONAL, 77(7), 637-644.

GFR estimating equations, CKD prevalence and the public health
Chang, T. I., & Chertow, G. M. (2010). GFR estimating equations, CKD prevalence and the public health. JOURNAL OF INTERNAL MEDICINE, 267(4), 354-356.

Shorter dialysis times are associated with higher mortality among incident hemodialysis patients
Brunelli, S. M., Chertow, G. M., Ankers, E. D., Lowrie, E. G., & Thadhani, R. (2010). Shorter dialysis times are associated with higher mortality among incident hemodialysis patients. KIDNEY INTERNATIONAL, 77(7), 630-636.

The elderly patients on hemodialysis
Anand, S., Tamura, M. K., & Chertow, G. M. (2010). The elderly patients on hemodialysis. MINERVA UROLOGICA E NEFROLOGICA, 62(1), 87-101.

Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease
Bibbins-Domingo, K., Chertow, G. M., Coxson, P. G., Moran, A., Lightwood, J. M., & Goldman, L. (2010). Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease. NEW ENGLAND JOURNAL OF MEDICINE, 362(7), 590-599.

Comparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury
Bouchard, J., Macedo, E., Soroko, S., Chertow, G. M., Himmelfarb, J., & Mehta, R. L. (2010). Comparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury. NEPHROLOGY DIALYSIS TRANSPLANTATION, 25(1), 102-107.

End-stage renal disease.
Abbasi, M. A., Chertow, G. M., & Hall, Y. N. (2010). End-stage renal disease. Clinical evidence.

Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients
Macedo, E., Bouchard, J., Soroko, S. H., Chertow, G. M., Himmelfarb, J., & Mehta, R. L. (2010). Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. CRITICAL CARE, 14(3).

Effects of Reduced Intradialytic Urea Generation Rate and Residual Renal Clearance on Modeled Urea Distribution Volume and Kt/V in Conventional, Daily, and Nocturnal Dialysis
Daugirdas, J. T., Depner, T. A., Greene, T., Levin, N. W., Chertow, G. M., & Stokes, J. B. (2010). Effects of Reduced Intradialytic Urea Generation Rate and Residual Renal Clearance on Modeled Urea Distribution Volume and Kt/V in Conventional, Daily, and Nocturnal Dialysis. SEMINARS IN DIALYSIS, 23(1), 19-24.

Preexisting Chronic Kidney Disease: A Potential for Improved Outcomes from Acute Kidney Injury
Khosla, N., Soroko, S. B., Chertow, G. M., Himmelfarb, J., Ikizler, T. A., & Mehta, R. L. (2009). Preexisting Chronic Kidney Disease: A Potential for Improved Outcomes from Acute Kidney Injury. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 4(12), 1914-1919.

Medication errors in chronic kidney disease: one piece in the patient safety puzzle
Fink, J. C., & Chertow, G. M. (2009). Medication errors in chronic kidney disease: one piece in the patient safety puzzle. KIDNEY INTERNATIONAL, 76(11), 1123-1125.

Increased fluid intake does not augment capacity to lay down new collagen in nursing home residents at risk for pressure ulcers: A randomized, controlled clinical trial
Stotts, N. A., Hopf, H. W., Kayser-Jones, J., Chertow, G. M., Cooper, B. A., & Wu, H.-S. (2009). Increased fluid intake does not augment capacity to lay down new collagen in nursing home residents at risk for pressure ulcers: A randomized, controlled clinical trial. WOUND REPAIR AND REGENERATION, 17(6), 780-788.

Fetuin-A and Change in Body Composition in Older Persons
Ix, J. H., Wassel, C. L., Chertow, G. M., Koster, A., Johnson, K. C., & Shlipak, M. G. (2009). Fetuin-A and Change in Body Composition in Older Persons. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 94(11), 4492-4498.

Functional Status of Elderly Adults before and after Initiation of Dialysis
Tamura, M. K., Covinsky, K. E., Chertow, G. M., Yaffe, K., Landefeld, C. S., & McCulloch, C. E. (2009). Functional Status of Elderly Adults before and after Initiation of Dialysis. NEW ENGLAND JOURNAL OF MEDICINE, 361(16), 1539-1547.

Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease
Lo, L. J., Go, A. S., Chertow, G. M., McCulloch, C. E., Fan, D., & Hsu, C.- yuan. (2009). Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. KIDNEY INTERNATIONAL, 76(8), 893-899.

Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury
Bouchard, J., Soroko, S. B., Chertow, G. M., Himmelfarb, J., Ikizler, T. A., & Mehta, R. L. (2009). Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. KIDNEY INTERNATIONAL, 76(4), 422-427.

Characteristics of Uninsured Americans with Chronic Kidney Disease
Hall, Y. N., Rodriguez, R. A., Boyko, E. J., Chertow, G. M., & O'Hare, A. M. (2009). Characteristics of Uninsured Americans with Chronic Kidney Disease. JOURNAL OF GENERAL INTERNAL MEDICINE, 24(8), 917-922.

Frailty and Chronic Kidney Disease: The Third National Health and Nutrition Evaluation Survey
Wilhelm-Leen, E. R., Hall, Y. N., Tamura, M. K., & Chertow, G. M. (2009). Frailty and Chronic Kidney Disease: The Third National Health and Nutrition Evaluation Survey. AMERICAN JOURNAL OF MEDICINE, 122(7), 664-U86.

A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: A new paradigm for clinical outcomes studies in nephrology
Block, G. A., Persky, M. S., Ketteler, M., Kestenbaum, B., Thadhani, R., & Wheeler, D. C. (2009). A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: A new paradigm for clinical outcomes studies in nephrology. HEMODIALYSIS INTERNATIONAL, 13(3), 360-362.

The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: A systematic review
Desai, A. A., Nissenson, A., Chertow, G. M., Farid, M., Singh, I., & Spiegel, B. Mr. (2009). The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: A systematic review. HEMODIALYSIS INTERNATIONAL, 13(3), 347-359.

Phosphorus binders and survival: need for randomized trials
Ix, J. H., & Chertow, G. M. (2009). Phosphorus binders and survival: need for randomized trials. NATURE REVIEWS NEPHROLOGY, 5(7), 368-370.

Melamine nephrotoxicity: an emerging epidemic in an era of globalization
Bhalla, V., Grimm, P. C., Chertow, G. M., & Pao, A. C. (2009). Melamine nephrotoxicity: an emerging epidemic in an era of globalization. KIDNEY INTERNATIONAL, 75(8), 774-779.

Cautious Optimism Concerning Long-Term Safety of Kidney Donation.
Tan, J. C., & Chertow, G. M. (2009). Cautious Optimism Concerning Long-Term Safety of Kidney Donation. NEW ENGLAND JOURNAL OF MEDICINE, 360(5), 522-523.

Choroidopathy and kidney disease: a case report and review of the literature.
Kamdar, N. V., Erko, A., Ehrlich, J. S., Kim, J. W., Kambham, N., & Chertow, G. M. (2009). Choroidopathy and kidney disease: a case report and review of the literature. Cases journal, 2, 7425-?.

Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study
Palevsky, P. M., O'Connor, T. Z., Chertow, G. M., Crowley, S. T., Zhang, J. H., & Kellum, J. A. (2009). Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study. CRITICAL CARE, 13(4).

An Empiric Estimate of the Value of Life: Updating the Renal Dialysis Cost-Effectiveness Standard
Lee, C. P., Chertow, G. M., & Zenios, S. A. (2009). An Empiric Estimate of the Value of Life: Updating the Renal Dialysis Cost-Effectiveness Standard. VALUE IN HEALTH, 12(1), 80-87.

Regional Variation in Kidney Transplant Outcomes: Trends Over Time
Chakkera, H. A., Chertow, G. M., O'Hare, A. M., Amend, W. J., & Gonwa, T. A. (2009). Regional Variation in Kidney Transplant Outcomes: Trends Over Time. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 4(1), 152-159.

Neighborhood poverty and kidney transplantation among US Asians and Pacific Islanders with end-stage renal disease
Halla, Y. N., O'Harea, A. M., Younga, B. A., Boyko, E. J., & Chertow, G. M. (2008). Neighborhood poverty and kidney transplantation among US Asians and Pacific Islanders with end-stage renal disease. AMERICAN JOURNAL OF TRANSPLANTATION, 8(11), 2402-2409.

Management of acute kidney injury in the intensive care unit - A cost-effectiveness analysis of daily vs alternate-day hemodialysis
Desai, A. A., Baras, J., Berk, B. B., Nakajima, A., Garber, A. M., & Chertow, G. M. (2008). Management of acute kidney injury in the intensive care unit - A cost-effectiveness analysis of daily vs alternate-day hemodialysis. ARCHIVES OF INTERNAL MEDICINE, 168(16), 1761-1767.

A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease
Xie, D., Joffe, M. M., Brunelli, S. M., Beck, G., Chertow, G. M., & Feldman, H. I. (2008). A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 3(5), 1332-1338.

Cost-effectiveness of frequent in-center hemodialysis
Lee, C. P., Zenios, S. A., & Chertow, G. M. (2008). Cost-effectiveness of frequent in-center hemodialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 19(9), 1792-1797.

Surface-Area-Normalized Kt/V: A Method of Rescaling Dialysis Dose to Body Surface Area-Implications for Different-Size Patients by Gender
Daugirdas, J. T., Depner, T. A., Greene, T., Kuhlmann, M. K., Levin, N. W., & Rocco, M. V. (2008). Surface-Area-Normalized Kt/V: A Method of Rescaling Dialysis Dose to Body Surface Area-Implications for Different-Size Patients by Gender. SEMINARS IN DIALYSIS, 21(5), 415-421.

Comparison of Proposed Alternative Methods for Rescaling Dialysis Close: Resting Energy Expenditure, High Metabolic Rate Organ Mass, Liver Size, and Body Surface Area
Daugirdas, J. T., Levin, N. W., Kotanko, P., Depner, T. A., Kuhlmann, M. K., & Rocco, M. V. (2008). Comparison of Proposed Alternative Methods for Rescaling Dialysis Close: Resting Energy Expenditure, High Metabolic Rate Organ Mass, Liver Size, and Body Surface Area. SEMINARS IN DIALYSIS, 21(5), 377-384.

Intensity of renal support in critically ill patients with acute kidney injury
Palevsky, P. M., Zhang, J. H., O'Connor, T. Z., Chertow, G. M., Crowley, S. T., & Peduzzi, P. (2008). Intensity of renal support in critically ill patients with acute kidney injury. NEW ENGLAND JOURNAL OF MEDICINE, 359(1), 7-20.

Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism
Block, G. A., Zeig, S., Sugihara, J., Chertow, G. M., Chi, E. M., & Bushinsky, D. A. (2008). Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism. NEPHROLOGY DIALYSIS TRANSPLANTATION, 23(7), 2311-2318.

Higher serum creatinine concentrations in black patients with chronic kidney disease: Beyond nutritional status and body composition
Hsu, J., Johansen, K. L., Hsu, C.-Y., Kaysen, G. A., & Chertow, G. M. (2008). Higher serum creatinine concentrations in black patients with chronic kidney disease: Beyond nutritional status and body composition. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 3(4), 992-997.

The risk of acute renal failure in patients with chronic kidney disease
Hsu, C. Y., Ordonez, J. D., Chertow, G. M., Fan, D., McCulloch, C. E., & Go, A. S. (2008). The risk of acute renal failure in patients with chronic kidney disease. KIDNEY INTERNATIONAL, 74(1), 101-107.

Lessons for successful study enrollment from the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study
Crowley, S. T., Chertow, G. M., Vitale, J., O'Connor, T., Zhang, J., & Palevsky, P. M. (2008). Lessons for successful study enrollment from the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 3(4), 955-961.

Trends and outcomes associated with serum albumin concentration among incident dialysis patients in the United States
Kaysen, G. A., Johansen, K. L., Cheng, S.-C., Jin, C., & Chertow, G. M. (2008). Trends and outcomes associated with serum albumin concentration among incident dialysis patients in the United States. JOURNAL OF RENAL NUTRITION, 18(4), 323-331.

High-molecular weight iron dextran: A wolf in sheep's clothing?
Rodgers, G. M., Auerbach, M., Cella, D., Chertow, G. M., Coyne, D. W., & Henry, D. H. (2008). High-molecular weight iron dextran: A wolf in sheep's clothing?. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 19(5), 833-834.

Diagnosis, epidemiology and outcomes of acute kidney injury
Waikar, S. S., Liu, K. D., & Chertow, G. M. (2008). Diagnosis, epidemiology and outcomes of acute kidney injury. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 3(3), 844-861.

Toward the promise of renal replacement therapy
Chertow, G. M., & Waikar, S. S. (2008). Toward the promise of renal replacement therapy. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 19(5), 839-840.

Kidney dysfunction and fatal cardiovascular disease - an association independent of atherosclerotic events: Results from the Health, Aging, and Body Composition (Health ABC) study
Deo, R., Fyr, C. Lw., Fried, L. F., Newman, A. B., Harris, T. B., & Shlipak, M. G. (2008). Kidney dysfunction and fatal cardiovascular disease - an association independent of atherosclerotic events: Results from the Health, Aging, and Body Composition (Health ABC) study. AMERICAN HEART JOURNAL, 155(1), 62-68.

Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury
Liu, K. D., Glidden, D. V., Eisner, M. D., Parsons, P. E., Ware, L. B., & Matthay, M. A. (2007). Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. CRITICAL CARE MEDICINE, 35(12), 2755-2761.

Significance of frailty among dialysis patients
Johansen, K. L., Chertow, G. M., Jin, C., & Kutner, N. G. (2007). Significance of frailty among dialysis patients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 18(11), 2960-2967.

Kidney function as a predictor of loss of lean mass in older adults: Health, aging and body composition study
Fried, L. F., Boudreau, R., Lee, J. S., Chertow, G., Kurella-Tamura, M., & Newman, A. B. (2007). Kidney function as a predictor of loss of lean mass in older adults: Health, aging and body composition study. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 55(10), 1578-1584.

Race and mortality after acute renal failure
Waikar, S. S., Curhan, G. C., Ayanian, J. Z., & Chertow, G. M. (2007). Race and mortality after acute renal failure. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 18(10), 2740-2748.

Chronic kidney disease mineral bone disorder and health-related quality of life among incident end-stage renal-disease patients
Johansen, K. L., & Chertow, G. M. (2007). Chronic kidney disease mineral bone disorder and health-related quality of life among incident end-stage renal-disease patients. JOURNAL OF RENAL NUTRITION, 17(5), 305-313.

Evaluation of cinacalcet therapy to lower cardiovascular events (EVOLVE): Rationale and design overview
Chertow, G. M., Pupim, L. B., Block, G. A., Correa-Rotter, R., Drueke, T. B., & Parfrey, P. (2007). Evaluation of cinacalcet therapy to lower cardiovascular events (EVOLVE): Rationale and design overview. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2(5), 898-905.

Rise of pay for performance: Implications for care of people with chronic kidney disease
Desai, A. A., Garber, A. M., & Chertow, G. M. (2007). Rise of pay for performance: Implications for care of people with chronic kidney disease. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2(5), 1087-1095.

Community-based incidence of acute renal failure
Hsu, C.- y, McCulloch, C. E., Fan, D., Ordonez, J. D., Chertow, G. M., & Go, A. S. (2007). Community-based incidence of acute renal failure. KIDNEY INTERNATIONAL, 72(2), 208-212.

Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease - Data from the heart and soul study
Ix, J. H., Chertow, G. M., Shlipak, M. G., Brandenburg, V. M., Ketteler, M., & Whooley, M. A. (2007). Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease - Data from the heart and soul study. CIRCULATION, 115(19), 2533-2539.

The incidence and prognostic significance of acute kidney injury
Waikar, S. S., Liu, K. D., & Chertow, G. M. (2007). The incidence and prognostic significance of acute kidney injury. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 16(3), 227-236.

Octogenarians and nonagenarians starting dialysis in the United States
Kurella, M., Covinsky, K. E., Collins, A. J., & Chertow, G. M. (2007). Octogenarians and nonagenarians starting dialysis in the United States. ANNALS OF INTERNAL MEDICINE, 146(3), 177-183.

Frequent Hemodialysis Network (FHN) randomized trials: Study design
Suri, R. S., Garg, A. X., Chertow, G. M., Levin, N. W., Rocco, M. V., & Kliger, A. S. (2007). Frequent Hemodialysis Network (FHN) randomized trials: Study design. KIDNEY INTERNATIONAL, 71(4), 349-359.

Phosphorus balance and mineral metabolism with 3 h daily hemodialysis
Ayus, J. C., Achinger, S. G., Mizani, M. R., Chertow, G. M., Furmaga, W., & Rodriguez, F. (2007). Phosphorus balance and mineral metabolism with 3 h daily hemodialysis. KIDNEY INTERNATIONAL, 71(4), 336-342.

Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease - Data from the Heart and Soul Study
Ix, J. H., Shlipak, M. G., Chertow, G. M., & Whooley, M. A. (2007). Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease - Data from the Heart and Soul Study. CIRCULATION, 115(2), 173-179.

End stage renal disease.
Hall, Y. N., & Chertow, G. M. (2007). End stage renal disease. Clinical evidence.

Cystatin C and measures of physical function in elderly adults - The health, aging, and body composition (HABC) study
Odden, M. C., Chertow, G. M., Fried, L. F., Newman, A. B., Connelly, S., & Shlipak, M. G. (2006). Cystatin C and measures of physical function in elderly adults - The health, aging, and body composition (HABC) study. AMERICAN JOURNAL OF EPIDEMIOLOGY, 164(12), 1180-1189.

Less-than-subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantation
Triponez, F., Kebebew, E., Dosseh, D., Duh, Q.-Y., Hazzan, M., & Clark, O. H. (2006). Less-than-subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantation. SURGERY, 140(6), 990-997.

Survival by dialysis modality in critically ill patients with acute kidney injury
Cho, K. C., Himmelfarb, J., Paganini, E., Ikizler, T. A., Soroko, S. H., & Chertow, G. M. (2006). Survival by dialysis modality in critically ill patients with acute kidney injury. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 17(11), 3132-3138.

Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease
Peralta, C. A., Shlipak, M. G., Fan, D., Ordonez, J., Lash, J. P., & Go, A. S. (2006). Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 17(10), 2892-2899.

Tesio catheter access for long-term maintenance hemodialysis
Wang, J., LaBerge, J. M., Chertow, G. M., Kerlan, R. K., Wilson, M. W., & Gordon, R. L. (2006). Tesio catheter access for long-term maintenance hemodialysis. RADIOLOGY, 241(1), 284-290.

Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: Data from The Heart and Soul Study
Ix, J. H., Shlipak, M. G., Chertow, G. M., Ali, S., Schiller, N. B., & Whooley, M. A. (2006). Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: Data from The Heart and Soul Study. JOURNAL OF CARDIAC FAILURE, 12(8), 601-607.

Studying the prevention of acute kidney injury: Lessons from an 18th-century mathematician
Chertow, G. M., Palevsky, P. M., & Greene, T. (2006). Studying the prevention of acute kidney injury: Lessons from an 18th-century mathematician. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1(5), 1124-1127.

A simulation model to estimate the cost and effectiveness of alternative dialysis initiation strategies
Lee, C. P., Chertow, G. M., & Zenios, S. A. (2006). A simulation model to estimate the cost and effectiveness of alternative dialysis initiation strategies. MEDICAL DECISION MAKING, 26(5), 535-549.

Timing of initiation of dialysis in critically ill patients with acute kidney injury
Liu, K. D., Himmelfarb, J., Paganini, E., Ikizler, T. A., Soroko, S. H., & Chertow, G. M. (2006). Timing of initiation of dialysis in critically ill patients with acute kidney injury. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1(5), 915-919.

Mortality after acute renal failure: Models for prognostic stratification and risk adjustment
Chertow, G. M., Soroko, S. H., Paganini, E. P., Cho, K. C., Himmelfarb, J., & Mehta, R. L. (2006). Mortality after acute renal failure: Models for prognostic stratification and risk adjustment. KIDNEY INTERNATIONAL, 70(6), 1120-1126.

Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study
Kurella, M., Mapes, D. L., Port, F. K., & Chertow, G. M. (2006). Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study. NEPHROLOGY DIALYSIS TRANSPLANTATION, 21(9), 2543-2548.

Fetuin-A and kidney function in persons with coronary artery disease-data from the heart and soul study
Ix, J. H., Chertow, G. M., Shlipak, M. G., Brandenburg, V. M., Ketteler, M., & Whooley, M. A. (2006). Fetuin-A and kidney function in persons with coronary artery disease-data from the heart and soul study. NEPHROLOGY DIALYSIS TRANSPLANTATION, 21(8), 2144-2151.

Renal function and heart failure risk in older black and white individuals - The health, aging, and body composition study
Bibbins-Domingo, K., Chertow, G. M., Fried, L. F., Odden, M. C., Newman, A. B., & Shlipak, M. G. (2006). Renal function and heart failure risk in older black and white individuals - The health, aging, and body composition study. ARCHIVES OF INTERNAL MEDICINE, 166(13), 1396-1402.

The metabolic syndrome and chronic kidney disease
Peralta, C. A., Kurella, M., Lo, J. C., & Chertow, G. M. (2006). The metabolic syndrome and chronic kidney disease. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 15(4), 361-365.

The tortoise and hare on hemodialysis: Does slow and steady win the race?
Chertow, G. M., Kurella, M., & Lowrie, E. G. (2006). The tortoise and hare on hemodialysis: Does slow and steady win the race?. KIDNEY INTERNATIONAL, 70(1), 24-25.

The case against calcium-based phosphate binders
Moe, S. M., & Chertow, G. M. (2006). The case against calcium-based phosphate binders. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1(4), 697-703.

Evolving practices in critical care and potential implications for management of acute kidney injury
Liu, K. D., Matthay, M. A., & Chertow, G. M. (2006). Evolving practices in critical care and potential implications for management of acute kidney injury. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1(4), 869-873.

Guidelines for disorders of mineral metabolism and secondary hyperparathyroidism should not yet be modified
Ix, J. H., Quarles, L. D., & Chertow, G. M. (2006). Guidelines for disorders of mineral metabolism and secondary hyperparathyroidism should not yet be modified. NATURE CLINICAL PRACTICE NEPHROLOGY, 2(6), 337-339.

The enlarging body of evidence: Obesity and chronic kidney disease
Chertow, G. M., Hsu, C.-Y., & Johansen, K. L. (2006). The enlarging body of evidence: Obesity and chronic kidney disease. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 17(6), 1501-1502.

Validity of International Classification of Diseases, Ninth Revision, Clinical Modification codes for acute renal failure
Waikar, S. S., Wald, R., Chertow, G. M., Curhan, G. C., Winkelmayer, W. C., & Jaber, B. L. (2006). Validity of International Classification of Diseases, Ninth Revision, Clinical Modification codes for acute renal failure. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 17(6), 1688-1694.

End stage renal disease.
Hall, Y. N., & Chertow, G. M. (2006). End stage renal disease. Clinical evidence, (15), 1171-1181.

Declining mortality in patients with acute renal failure, 1988 to 2002
Waikar, S. S., Curhan, G. C., Wald, R., McCarthy, E. P., & Chertow, G. M. (2006). Declining mortality in patients with acute renal failure, 1988 to 2002. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 17(4), 1143-1150.

Association of body size with health status in patients beginning dialysis
Johansen, K. L., Kutner, N. G., Young, B., & Chertow, G. M. (2006). Association of body size with health status in patients beginning dialysis. AMERICAN JOURNAL OF CLINICAL NUTRITION, 83(3), 543-549.

Strategies for successful patient oriented research: Why did I (not) get funded?
Agarwal, R., Chertow, G. M., & Mehta, R. L. (2006). Strategies for successful patient oriented research: Why did I (not) get funded?. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1(2), 340-343.

Acute renal failure after endovascular vs open repair of abdominal aortic aneurysm
Wald, R., Waikar, S. S., Liangos, O., Pereira, B. Jg., Chertow, G. M., & Jaber, B. L. (2006). Acute renal failure after endovascular vs open repair of abdominal aortic aneurysm. JOURNAL OF VASCULAR SURGERY, 43(3), 460-466.

Cinacalcet hydrochloride (sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate
Chertow, G. M., Blumenthal, S., Turner, S., Roppolo, M., Stern, L., & Reed, J. (2006). Cinacalcet hydrochloride (sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1(2), 305-312.

Update on adverse drug events associated with parenteral iron
Chertow, G. M., Mason, P. D., Vaage-Nilsen, O., & Ahlmen, J. (2006). Update on adverse drug events associated with parenteral iron. NEPHROLOGY DIALYSIS TRANSPLANTATION, 21(2), 378-382.

Challenging the validity of the EPO index.
Kaysen, G. A., Müller, H. G., Ding, J., & Chertow, G. M. (2006). Challenging the validity of the EPO index. American journal of kidney diseases , 47(1), 166-?.

Cystatin C and mortality risk in the elderly: The health, aging, and body composition study
Shlipak, M. G., Fyr, C. Lw., Chertow, G. M., Harris, T. B., Kritchevsky, S. B., & Fried, L. F. (2006). Cystatin C and mortality risk in the elderly: The health, aging, and body composition study. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 17(1), 254-261.

PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis
Danese, M. D., Kim, J., Doan, Q. V., Dylan, M., Griffiths, R., & Chertow, G. M. (2006). PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. AMERICAN JOURNAL OF KIDNEY DISEASES, 47(1), 149-156.

Lessons for Medicare Part D in the hemodialysis community.
Nayeem, A. I., & Chertow, G. M. (2006). Lessons for Medicare Part D in the hemodialysis community. BMC nephrology, 7, 11-?.

Health-related quality of life and estimates of utility in chronic kidney disease
Gorodetskaya, I., Zenios, S., McCulloch, C. E., Bostrom, A., Hsu, C. Y., & Chertow, G. M. (2005). Health-related quality of life and estimates of utility in chronic kidney disease. KIDNEY INTERNATIONAL, 68(6), 2801-2808.

Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients
Chertow, G. M., Goldstein-Fuchs, D. J., Lazarus, J. M., & Kaysen, G. A. (2005). Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients. KIDNEY INTERNATIONAL, 68(6), 2794-2800.

Self-reported appetite, hospitalization and death in haemodialysis patients: findings from the hemodialysis (HEMO) study
Burrowes, J. D., Larive, B., Chertow, G. M., Cockram, D. B., Dwyer, J. T., & Rocco, M. V. (2005). Self-reported appetite, hospitalization and death in haemodialysis patients: findings from the hemodialysis (HEMO) study. NEPHROLOGY DIALYSIS TRANSPLANTATION, 20(12), 2765-2774.

Differential mortality and transplantation rates among Asians and Pacific Islanders with ESRD
Hall, Y. N., Sugihara, J. G., Go, A. S., & Chertow, G. M. (2005). Differential mortality and transplantation rates among Asians and Pacific Islanders with ESRD. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(12), 3711-3720.

Acute kidney injury, mortality, length of stay, and costs in hospitalized patients
Chertow, G. M., Burdick, E., Honour, M., Bonventre, J. V., & Bates, D. W. (2005). Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(11), 3365-3370.

Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism
Cunningham, J., Danese, M., Olson, K., Klassen, P., & Chertow, G. M. (2005). Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. KIDNEY INTERNATIONAL, 68(4), 1793-1800.

Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study ?
Dwyer, J. T., Larive, B., Leung, J., Rocco, M. V., Greene, T., & Kusek, J. W. (2005). Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study ?. KIDNEY INTERNATIONAL, 68(4), 1766-1776.

Insulin resistance in critically ill patients with acute renal failure
Basi, S., Pupim, L. B., Simmons, E. M., Sezer, M. T., Shyr, Y., & Ikizler, T. A. (2005). Insulin resistance in critically ill patients with acute renal failure. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 289(2), F259-F264.

Chronic kidney disease and cognitive impairment in the elderly: The health, aging, and body composition study
Kurella, M., Chertow, G. M., Fried, L. F., Cummings, S. R., Harris, T., & Yaffe, K. (2005). Chronic kidney disease and cognitive impairment in the elderly: The health, aging, and body composition study. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(7), 2127-2133.

Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults
Kurella, M., Lo, J. C., & Chertow, G. M. (2005). Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(7), 2134-2140.

Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates
Kirtane, A. J., Leder, D. M., Waikar, S. S., Chertow, G. M., Ray, K. K., & Gibson, C. M. (2005). Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 45(11), 1781-1786.

Control of hypertension in adults with chronic kidney disease in the United States
Peralta, C. A., Hicks, L. S., Chertow, G. M., Ayanian, J. Z., Vittinghoff, E., & Shlipak, M. G. (2005). Control of hypertension in adults with chronic kidney disease in the United States. HYPERTENSION, 45(6), 1119-1124.

Beyond Framingham: Cardiovascular risk profiling in ESRD
McClellan, W. M., & Chertow, G. M. (2005). Beyond Framingham: Cardiovascular risk profiling in ESRD. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(6), 1539-1541.

End stage renal disease.
Hall, Y., & Chertow, G. (2005). End stage renal disease. Clinical evidence, (13), 1048-1059.

Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients
Ferramosca, E., Burke, S., Chasan-Taber, S., Ratti, C., Chertow, G. M., & Raggi, P. (2005). Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients. AMERICAN HEART JOURNAL, 149(5), 820-825.

Medicare ESRD prospective payment system: Weighing the evidence
Himmelfarb, J., & Chertow, G. M. (2005). Medicare ESRD prospective payment system: Weighing the evidence. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(5), 1164-1165.

Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis
Raggi, P., James, G., Burke, S. K., Bommer, J., Chasan-Taber, S., & Chertow, G. M. (2005). Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis. JOURNAL OF BONE AND MINERAL RESEARCH, 20(5), 764-772.

Bone disease and bottle caps
Tichy, M., Garg, J. P., Cho, K. C., & Chertow, G. M. (2005). Bone disease and bottle caps. JOURNAL OF RENAL NUTRITION, 15(2), 257-259.

Frequent hemodialysis and psychosocial function
Kurella, M., Suri, R. S., & Chertow, G. M. (2005). Frequent hemodialysis and psychosocial function. SEMINARS IN DIALYSIS, 18(2), 132-136.

Suicide in the United States end-stage renal disease program
Kurella, M., Kimmel, P. L., Young, B. S., & Chertow, G. M. (2005). Suicide in the United States end-stage renal disease program. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(3), 774-781.

Dialysis session length ("t") as a determinant of the adequacy of dialysis
Kurella, M., & Chertow, G. M. (2005). Dialysis session length ("t") as a determinant of the adequacy of dialysis. SEMINARS IN NEPHROLOGY, 25(2), 90-95.

Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease
Lo, J. C., Chertow, G. M., Go, A. S., & Hsu, C. Y. (2005). Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. KIDNEY INTERNATIONAL, 67(3), 1047-1052.

Achieving NKF-K/DOQI (TM) bone metabolism and disease treatment goals with cinacalcet HCl
Moe, S. M., Chertow, G. M., Coburn, J. W., Quarles, L. D., Goodman, W. G., & Martin, K. J. (2005). Achieving NKF-K/DOQI (TM) bone metabolism and disease treatment goals with cinacalcet HCl. KIDNEY INTERNATIONAL, 67(2), 760-771.

Calcification or classification?
Chertow, G. M., & Moe, S. M. (2005). Calcification or classification?. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(2), 293-295.

Self-assessed sleep quality in chronic kidney disease.
Kurella, M., Luan, J., Lash, J. P., & Chertow, G. M. (2005). Self-assessed sleep quality in chronic kidney disease. International urology and nephrology, 37(1), 159-165.

Influence of race on kidney transplant outcomes within and outside the department of veterans affairs
Chakkera, H. A., O'Hare, A. M., Johansen, K. L., Hynes, D., Stroupe, K., & Chertow, G. M. (2005). Influence of race on kidney transplant outcomes within and outside the department of veterans affairs. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(1), 269-277.

Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis - A randomized clinical trial
Garg, J. P., Chasan-Taber, S., Blair, A., Plone, M., Bommer, J., & Chertow, G. M. (2005). Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis - A randomized clinical trial. ARTHRITIS AND RHEUMATISM, 52(1), 290-295.

Angiotensin receptor blockade and arterial compliance in chronic kidney disease: A pilot study
Garg, J. P., Ellis, R., Elliott, W. J., Hasabou, N., Chua, D., & Bakris, G. L. (2005). Angiotensin receptor blockade and arterial compliance in chronic kidney disease: A pilot study. AMERICAN JOURNAL OF NEPHROLOGY, 25(4), 393-399.

Chronic kidney disease and cognitive impairment in menopausal women
Kurella, M., Yaffe, K., Shlipak, M. G., Wenger, N. K., & Chertow, G. M. (2005). Chronic kidney disease and cognitive impairment in menopausal women. AMERICAN JOURNAL OF KIDNEY DISEASES, 45(1), 66-76.

Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction - The Survival and Ventricular Enlargement (SAVE) study
Tokmakova, M. P., Skali, H., Kenchaiah, S., Braunwald, E., Rouleau, J. L., & Solomon, S. D. (2004). Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction - The Survival and Ventricular Enlargement (SAVE) study. CIRCULATION, 110(24), 3667-3673.

Validation of the kidney disease quality of life (KDQOL) cognitive function subscale
Kurella, M., Luan, J., Yaffe, K., & Chertow, G. M. (2004). Validation of the kidney disease quality of life (KDQOL) cognitive function subscale. KIDNEY INTERNATIONAL, 66(6), 2361-2367.

Cognitive impairment in chronic kidney disease
Kurella, M., Chertow, G. M., Luan, J., & Yaffe, K. (2004). Cognitive impairment in chronic kidney disease. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 52(11), 1863-1869.

Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis
Ix, J. H., McCulloch, C. E., & Chertow, G. M. (2004). Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis. NEPHROLOGY DIALYSIS TRANSPLANTATION, 19(11), 2747-2753.

Spectrum of acute renal failure in the intensive care unit: The PICARD experience
Mehta, R. L., Pascual, M. T., Soroko, S., Savage, B. R., Himmelfarb, J., & Chertow, G. M. (2004). Spectrum of acute renal failure in the intensive care unit: The PICARD experience. KIDNEY INTERNATIONAL, 66(4), 1613-1621.

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D. J., McCulloch, C. E., & Hsu, C. Y. (2004). Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. NEW ENGLAND JOURNAL OF MEDICINE, 351(13), 1296-1305.

Race/ethnicity and disease severity in IgA nephropathy.
Hall, Y. N., Fuentes, E. F., Chertow, G. M., & Olson, J. L. (2004). Race/ethnicity and disease severity in IgA nephropathy. BMC nephrology, 5, 10-?.

Diminishing significance of HLA matching in kidney transplantation
Su, X. M., Zenios, S. A., Chakkera, H., Milford, E. L., & Chertow, G. M. (2004). Diminishing significance of HLA matching in kidney transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 4(9), 1501-1508.

Vector length as a proxy for the adequacy of ultrafiltration in hemodialysis
Pillon, L., Piccoli, A., Lowrie, E. G., Lazarus, J. M., & Chertow, G. M. (2004). Vector length as a proxy for the adequacy of ultrafiltration in hemodialysis. KIDNEY INTERNATIONAL, 66(3), 1266-1271.

"Renalism": Inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency
Chertow, G. M., Normand, S. Lt., & McNeil, B. J. (2004). "Renalism": Inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 15(9), 2462-2468.

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
Block, G. A., Klassen, P. S., Lazarus, J. M., Ofsthun, N., Lowrie, E. G., & Chertow, G. M. (2004). Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 15(8), 2208-2218.

Association of body size with outcomes among patients beginning dialysis
Johansen, K. L., Young, B., Kaysen, G. A., & Chertow, G. M. (2004). Association of body size with outcomes among patients beginning dialysis. AMERICAN JOURNAL OF CLINICAL NUTRITION, 80(2), 324-332.

Coronary and aortic calcifications in patients new to dialysis.
Spiegel, D. M., Raggi, P., Mehta, R., Lindberg, J. S., Chonchol, M., & Block, G. A. (2004). Coronary and aortic calcifications in patients new to dialysis. Hemodialysis international. International Symposium on Home Hemodialysis, 8(3), 265-272.

Incorporating recipient choice in kidney transplantation
Su, X. M., Zenios, S. A., & Chertow, G. M. (2004). Incorporating recipient choice in kidney transplantation. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 15(6), 1656-1663.

On the relative safety of parenteral iron formulations
Chertow, G. M., Mason, P. D., Vaage-Nilsen, O., & Ahlmen, J. (2004). On the relative safety of parenteral iron formulations. NEPHROLOGY DIALYSIS TRANSPLANTATION, 19(6), 1571-1575.

Determinants of progressive vascular calcification in haemodialysis patients
Chertow, G. M., Raggi, P., Chasan-Taber, S., Bommer, J., Holzer, H., & Burke, S. K. (2004). Determinants of progressive vascular calcification in haemodialysis patients. NEPHROLOGY DIALYSIS TRANSPLANTATION, 19(6), 1489-1496.

Prevention of radiocontrast nephropathy - Back to basics
Chertow, G. M. (2004). Prevention of radiocontrast nephropathy - Back to basics. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 291(19), 2376-2377.

Screening to prevent coronary events or screening to detect obstruction?
Raggi, P., Budoff, M. J., & Chertow, G. M. (2004). Screening to prevent coronary events or screening to detect obstruction?. AMERICAN JOURNAL OF KIDNEY DISEASES, 43(5), 940-940.

Physical and sexual function in women with chronic kidney disease
Kurella, M., Ireland, C., Hlatky, M. A., Shlipak, M. G., Yaffe, K., & Chertow, G. M. (2004). Physical and sexual function in women with chronic kidney disease. AMERICAN JOURNAL OF KIDNEY DISEASES, 43(5), 868-876.

The influence of patient- and facility-specific factors on nutritional status and survival in hemodialysis
Kaysen, G. A., Muller, H. G., Young, B. S., Leng, X. Y., & Chertow, G. M. (2004). The influence of patient- and facility-specific factors on nutritional status and survival in hemodialysis. JOURNAL OF RENAL NUTRITION, 14(2), 72-81.

Plasma cytokine levels predict mortality in patients with acute renal failure
Simmons, E. M., Himmelfarb, J., Sezer, M. T., Chertow, G. M., Mehta, R. L., & Ikizler, T. A. (2004). Plasma cytokine levels predict mortality in patients with acute renal failure. KIDNEY INTERNATIONAL, 65(4), 1357-1365.

A 43-year-old woman with chronic renal insufficiency
Chertow, G. M. (2004). A 43-year-old woman with chronic renal insufficiency. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 291(10), 1252-1259.

Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus, binders or sevelamer
Raggi, P., Bommer, J., & Chertow, G. M. (2004). Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus, binders or sevelamer. JOURNAL OF HEART VALVE DISEASE, 13(1), 134-141.

Anthropometrically estimated total body water volumes are larger than modeled urea volume in chronic hemodialysis patients: Effects of age, race, and gender
Daugirdas, J. T., Greene, T., Depner, T. A., Chumlea, C., Rocco, M. J., & Chertow, G. M. (2003). Anthropometrically estimated total body water volumes are larger than modeled urea volume in chronic hemodialysis patients: Effects of age, race, and gender. KIDNEY INTERNATIONAL, 64(3), 1108-1119.

Reasons for non-enrollment in a cohort study of ARF: The program to improve care in acute renal disease (PICARD) experience and implications for a clinical trials network
Chertow, G. M., Pascual, M. T., Soroko, S., Savage, B. R., Himmelfarb, J., & Mehta, R. L. (2003). Reasons for non-enrollment in a cohort study of ARF: The program to improve care in acute renal disease (PICARD) experience and implications for a clinical trials network. AMERICAN JOURNAL OF KIDNEY DISEASES, 42(3), 507-512.

The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients
Chertow, G. M., Raggi, P., McCarthy, J. T., Schulman, G., Silberzweig, J., & Toto, R. D. (2003). The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients. AMERICAN JOURNAL OF NEPHROLOGY, 23(5), 307-314.

Slowing the progression of vascular calcification in hemodialysis
Chertow, G. M. (2003). Slowing the progression of vascular calcification in hemodialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 14(9), S310-S314.

Acute renal failure definitions and classification: Time for change?
Mehta, R. L., & Chertow, G. M. (2003). Acute renal failure definitions and classification: Time for change?. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 14(8), 2178-2187.

Analgesia in patients with ESRD: A review of available evidence
Kurella, M., Bennett, W. M., & Chertow, G. M. (2003). Analgesia in patients with ESRD: A review of available evidence. AMERICAN JOURNAL OF KIDNEY DISEASES, 42(2), 217-228.

Inflammatory markers are unrelated to physical activity, performance, and functioning in hemodialysis
Hung, A. M., Chertow, G. A., Young, B. S., Carey, S., & Johansen, K. L. (2003). Inflammatory markers are unrelated to physical activity, performance, and functioning in hemodialysis. ADVANCES IN RENAL REPLACEMENT THERAPY, 10(3), 232-240.

The Chronic Renal Insufficiency Cohort (CRIC) study: Design and methods
Feldman, H. I., Appel, L. J., Chertow, G. M., Cifelli, D., Cizman, B., & Wright, J. T. (2003). The Chronic Renal Insufficiency Cohort (CRIC) study: Design and methods. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 14(7), S148-S153.

Longitudinal study of nutritional status, body composition, and physical function in hemodialysis patients
Johansen, K. L., Kaysen, G. A., Young, B. S., Hung, A. M., Da Silva, M., & Chertow, G. M. (2003). Longitudinal study of nutritional status, body composition, and physical function in hemodialysis patients. AMERICAN JOURNAL OF CLINICAL NUTRITION, 77(4), 842-846.

Beware the rising creatinine level
Shlipak, M. G., Chertow, G. C., & Massie, B. M. (2003). Beware the rising creatinine level. JOURNAL OF CARDIAC FAILURE, 9(1), 26-28.

In critically ill patients with acute renal failure, outcomes, not dollars, should drive modality choice
Mehta, R. L., & Chertow, G. M. (2003). In critically ill patients with acute renal failure, outcomes, not dollars, should drive modality choice. CRITICAL CARE MEDICINE, 31(2), 644-646.

The decline in residual renal function in hemodialysis is slow and age dependent.
Hung, A. M., Young, B. S., & Chertow, G. M. (2003). The decline in residual renal function in hemodialysis is slow and age dependent. Hemodialysis international. International Symposium on Home Hemodialysis, 7(1), 17-22.

Diuretics, mortality, and nonrecovery of renal function in acute renal
Mehta, R. L., Pascual, M. T., Soroko, S., & Chertow, G. M. (2002). Diuretics, mortality, and nonrecovery of renal function in acute renal. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 288(20), 2547-2553.

The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease
de Boer, I. H., Gorodetskaya, I., Young, B., Hsu, C. Y., & Chertow, G. M. (2002). The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 13(11), 2762-2769.

Nephrology consultation in acute renal failure: Does timing matter?
Mehta, R. L., McDonald, B., Gabbai, F., Pahl, M., Farkas, A., & Chertow, G. M. (2002). Nephrology consultation in acute renal failure: Does timing matter?. AMERICAN JOURNAL OF MEDICINE, 113(6), 456-461.

Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients
Shlipak, M. G., Heidenreich, P. A., Noguchi, H., Chertow, G. M., Browner, W. S., & McClellan, M. B. (2002). Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. ANNALS OF INTERNAL MEDICINE, 137(7), 555-562.

Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency
Hsu, C. Y., & Chertow, G. M. (2002). Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. NEPHROLOGY DIALYSIS TRANSPLANTATION, 17(8), 1419-1425.

Inflammatory markers are unrelated to physical activity, performance, and functioning in hemodialysis
Hung, A. M., Chertow, G. M., Young, B. S., Carey, S., & Johansen, K. L. (2002). Inflammatory markers are unrelated to physical activity, performance, and functioning in hemodialysis. JOURNAL OF RENAL NUTRITION, 12(3), 170-176.

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
Chertow, G. M., Burke, S. K., & Raggi, P. (2002). Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. KIDNEY INTERNATIONAL, 62(1), 245-252.

Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency
Hsu, C. Y., Chertow, G. M., & Curhan, G. C. (2002). Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. KIDNEY INTERNATIONAL, 61(5), 1567-1576.

Refining predictive models in critically ill patients with acute renal failure
Mehta, R. L., Pascual, M. T., Gruta, C. G., Zhuang, S. P., & Chertow, G. M. (2002). Refining predictive models in critically ill patients with acute renal failure. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 13(5).

Bone mineral density is not diminished by mild to moderate chronic renal insufficiency
Hsu, C. Y., Cummings, S. R., McCulloch, C. E., & Chertow, G. A. (2002). Bone mineral density is not diminished by mild to moderate chronic renal insufficiency. KIDNEY INTERNATIONAL, 61(5), 1814-1820.

With bioimpedance spectroscopy, the errors get fat when the patients get slim
Chertow, G. M. (2002). With bioimpedance spectroscopy, the errors get fat when the patients get slim. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 26(2), 128-129.

Cardiac calcification in adult Hemodialysis patients - A link between end-stage renal disease and cardiovascular disease?
Raggi, P., Boulay, A., Chasan-Taber, S., Amin, N., Dillon, M., & Chertow, G. M. (2002). Cardiac calcification in adult Hemodialysis patients - A link between end-stage renal disease and cardiovascular disease?. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 39(4), 695-701.

Renal insufficiency with monoclonal gammopathy and urticarial vasculitis
O''Hare, A., Olson, J. L., Connolly, M. K., Ward, J. W., Stein, P., & Chertow, G. M. (2002). Renal insufficiency with monoclonal gammopathy and urticarial vasculitis. AMERICAN JOURNAL OF KIDNEY DISEASES, 39(1), 203-207.

Guided medication dosing for inpatients with renal insufficiency
Chertow, G. M., Lee, J., Kuperman, G. J., Burdick, E., Horsky, J., & Bates, D. W. (2001). Guided medication dosing for inpatients with renal insufficiency. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 286(22), 2839-2844.

"Wishing don't make it so" - Why we need a randomized clinical trial of high-intensity hemodialysis
Chertow, G. M. (2001). "Wishing don't make it so" - Why we need a randomized clinical trial of high-intensity hemodialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 12(12), 2850-2853.

Determinants of physical performance in ambulatory patients on hemodialysis
Johansen, K. L., Chertow, G. M., Da Silva, M., Carey, S., & Painter, P. (2001). Determinants of physical performance in ambulatory patients on hemodialysis. KIDNEY INTERNATIONAL, 60(4), 1586-1591.

Correlates of acute renal failure in patients receiving parenteral amphotericin B
Bates, D. W., Su, L., Yu, D. T., Chertow, G. M., Seger, D. L., & Platt, R. (2001). Correlates of acute renal failure in patients receiving parenteral amphotericin B. KIDNEY INTERNATIONAL, 60(4), 1452-1459.

Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients
Kaysen, G. A., Chertow, G. M., Adhikarla, R., Young, B., Ronco, C., & Levin, N. W. (2001). Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. KIDNEY INTERNATIONAL, 60(1), 333-340.

Cardiac arrest and sudden death in dialysis units
Karnik, J. A., Young, B. S., Lew, N. L., Herget, M., Dubinsky, C., & Chertow, G. M. (2001). Cardiac arrest and sudden death in dialysis units. KIDNEY INTERNATIONAL, 60(1), 350-357.

Suspected iron dextran-related adverse drug events in hemodialysis patients
Fletes, R., Lazarus, J. M., Gage, J., & Chertow, G. M. (2001). Suspected iron dextran-related adverse drug events in hemodialysis patients. AMERICAN JOURNAL OF KIDNEY DISEASES, 37(4), 743-749.

Mortality and costs of acute renal failure associated with amphotericin B therapy
Bates, D. W., Su, L., Yu, D. T., Chertow, G. M., Seger, D. L., & Platt, R. (2001). Mortality and costs of acute renal failure associated with amphotericin B therapy. CLINICAL INFECTIOUS DISEASES, 32(5), 686-693.

beta(2)-microglobulin modified with advanced glycation end products delays monocyte apoptosis
Hou, F. F., Miyata, T., Boyce, J., Yuan, Q., Chertow, G. M., & Owen, W. F. (2001). beta(2)-microglobulin modified with advanced glycation end products delays monocyte apoptosis. KIDNEY INTERNATIONAL, 59(3), 990-1002.

Validation of questionnaires to estimate physical activity and functioning in end-stage renal disease
Johansen, K. L., Painter, P., Kent-Braun, J. A., Ng, A. V., Carey, S., & Chertow, G. M. (2001). Validation of questionnaires to estimate physical activity and functioning in end-stage renal disease. KIDNEY INTERNATIONAL, 59(3), 1121-1127.

Gridlock on the road to kidney transplantation
Chertow, G. M., & Zenios, S. A. (2001). Gridlock on the road to kidney transplantation. AMERICAN JOURNAL OF KIDNEY DISEASES, 37(2), 435-437.

Mechanisms underlying renoprotection during renin-angiotensin system blockade
Taal, M. W., Chertow, G. M., Rennke, H. G., Gurnani, A., Jiang, T., & Mackenzie, H. S. (2001). Mechanisms underlying renoprotection during renin-angiotensin system blockade. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 280(2), F343-F355.

Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients
Chertow, G. M., Ackert, K., Lew, N. L., Lazarus, J. M., & Lowrie, E. G. (2000). Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients. KIDNEY INTERNATIONAL, 58(6), 2512-2517.

Hyperparathyroidism and dialysis vintage
Chertow, G. M., Plone, M., DILLON, M. A., Burke, S. K., & Slatopolsky, E. (2000). Hyperparathyroidism and dialysis vintage. CLINICAL NEPHROLOGY, 54(4), 295-300.

Atrial natriuretic factor in oliguric acute renal failure
Lewis, J., Salem, M. M., Chertow, G. M., Weisberg, L. S., McGrew, F., & Allgren, R. L. (2000). Atrial natriuretic factor in oliguric acute renal failure. AMERICAN JOURNAL OF KIDNEY DISEASES, 36(4), 767-774.

Crystalloids versus colloids for resuscitation in shock
Waikar, S. S., & Chertow, G. M. (2000). Crystalloids versus colloids for resuscitation in shock. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 9(5), 501-504.

Chronic renal confusion: Insufficiency, failure, dysfunction, or disease
Hsu, C., & Chertow, G. M. (2000). Chronic renal confusion: Insufficiency, failure, dysfunction, or disease. AMERICAN JOURNAL OF KIDNEY DISEASES, 36(2), 415-418.

Dynamic allocation of kidneys to candidates on the transplant waiting list
Zenios, S. Aa., Chertow, G. M., & Wein, L. M. (2000). Dynamic allocation of kidneys to candidates on the transplant waiting list. OPERATIONS RESEARCH, 48(4), 549-569.

Sevelamer with and without calcium and vitamin D: observations from a long-term open-label clinical trial.
Chertow, G. M., DILLON, M. A., Amin, N., & Burke, S. K. (2000). Sevelamer with and without calcium and vitamin D: observations from a long-term open-label clinical trial. Journal of renal nutrition , 10(3), 125-132.

Ochrobactrum anthropi bacteremia in a patient on hemodialysis
Chertow, G. M. (2000). Ochrobactrum anthropi bacteremia in a patient on hemodialysis. AMERICAN JOURNAL OF KIDNEY DISEASES, 35(6).

Predicting acute renal failure after coronary bypass surgery: Cross-validation of two risk-stratification algorithms
Fortescue, E. B., Bates, D. W., & Chertow, G. M. (2000). Predicting acute renal failure after coronary bypass surgery: Cross-validation of two risk-stratification algorithms. KIDNEY INTERNATIONAL, 57(6), 2594-2602.

Physical activity levels in patients on hemodialysis and healthy sedentary controls
Johansen, K. L., Chertow, G. M., Ng, A. V., Mulligan, K., Carey, S., & Kent-Braun, J. A. (2000). Physical activity levels in patients on hemodialysis and healthy sedentary controls. KIDNEY INTERNATIONAL, 57(6), 2564-2570.

Leveling the "paying" field in end-stage renal disease
Chertow, G. M. (2000). Leveling the "paying" field in end-stage renal disease. AMERICAN JOURNAL OF MEDICINE, 108(8), 666-668.

Survival after acute myocardial infarction in patients with end-stage renal disease: Results from the Cooperative Cardiovascular Project
Chertow, G. M., Normand, S. Lt., Silva, L. R., & McNeil, B. J. (2000). Survival after acute myocardial infarction in patients with end-stage renal disease: Results from the Cooperative Cardiovascular Project. AMERICAN JOURNAL OF KIDNEY DISEASES, 35(6), 1044-1051.

Issues in renal nutrition for persons from the former Soviet Union.
Gorodetskaya, I., Matel, J., & Chertow, G. M. (2000). Issues in renal nutrition for persons from the former Soviet Union. Journal of renal nutrition , 10(2), 98-102.

Acute renal failure with interstitial nephritis in a patient with AIDS
Mouratoff, J. G., Tokumoto, J., Olson, J. L., & Chertow, G. M. (2000). Acute renal failure with interstitial nephritis in a patient with AIDS. AMERICAN JOURNAL OF KIDNEY DISEASES, 35(3), 557-561.

Vintage, nutritional status, and survival in hemodialysis patients
Chertow, G. M., Johansen, K. L., Lew, N., Lazarus, J. M., & Lowrie, E. G. (2000). Vintage, nutritional status, and survival in hemodialysis patients. KIDNEY INTERNATIONAL, 57(3), 1176-1181.

Reply from the authors
Chertow, G. M. (2000). Reply from the authors. Kidney international, 58(3), 1358-9.

Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients
Chertow, G. M., Burke, S. K., Dillon, M. A., & Slatopolsky, E. (2000). Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 15(4), 559.

Renal nutrition in the new millennium.
Chertow, G. M. (2000). Renal nutrition in the new millennium. Journal of renal nutrition , 10(1), 1-?.

Exploring the reverse J-shaped curve between urea reduction ratio and mortality
Chertow, G. M., Owen, W. F., Lazarus, J. M., Lew, N. L., & Lowrie, E. G. (1999). Exploring the reverse J-shaped curve between urea reduction ratio and mortality. KIDNEY INTERNATIONAL, 56(5), 1872-1878.

Bioelectrical impedance methods in clinical research: A follow-up to the NIH technology assessment conference
Ellis, K. J., Bell, S. J., Chertow, G. M., Chumlea, W. C., Knox, T. A., & Schoeller, D. A. (1999). Bioelectrical impedance methods in clinical research: A follow-up to the NIH technology assessment conference. NUTRITION, 15(11-12), 874-880.

The urea {clearance x dialysis time} product (Kt) as an outcome-based measure of hemodialysis dose
Lowrie, E. G., Chertow, G. M., Lew, N. L., Lazarus, J. M., & Owen, W. F. (1999). The urea {clearance x dialysis time} product (Kt) as an outcome-based measure of hemodialysis dose. KIDNEY INTERNATIONAL, 56(2), 729-737.

Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure
Weinfeld, M. S., Chertow, G. M., & Stevenson, L. W. (1999). Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. AMERICAN HEART JOURNAL, 138(2), 285-290.

Estimates of body composition as intermediate outcome variables: are DEXA and BIA ready for prime time?
Chertow, G. M. (1999). Estimates of body composition as intermediate outcome variables: are DEXA and BIA ready for prime time?. Journal of renal nutrition , 9(3), 138-141.

Evidence-based organ allocation
Zenios, S. A., Wein, L. M., & Chertow, G. M. (1999). Evidence-based organ allocation. AMERICAN JOURNAL OF MEDICINE, 107(1), 52-61.

Metabolic and monetary casts of avoidable parenteral nutrition use
Trujillo, E. B., Young, L. S., Chertow, G. M., Randall, S., Clemons, T., & Robinson, M. K. (1999). Metabolic and monetary casts of avoidable parenteral nutrition use. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 23(2), 109-113.

Modality-specific nutrition support in ESRD: Weighing the evidence
Chertow, G. M. (1999). Modality-specific nutrition support in ESRD: Weighing the evidence. AMERICAN JOURNAL OF KIDNEY DISEASES, 33(1), 193-197.

A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium - Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients
Chertow, G. M., Dillon, M., Burke, S. K., Steg, M., Bleyer, A. J., & Slatopolsky, E. (1999). A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium - Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients. CLINICAL NEPHROLOGY, 51(1), 18-26.

Dose of hemodialysis and survival - Differences by race and sex
Owen, W. F., Chertow, G. M., Lazarus, J. M., & Lowrie, E. G. (1998). Dose of hemodialysis and survival - Differences by race and sex. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 280(20), 1764-1768.

Clearance of Pneumocystis carinii cysts in acute P carinii pneumonia - Assessment by serial sputum induction
O'Donnell, W. J., Pieciak, W., Chertow, G. M., Sanabria, J., & Lahive, K. C. (1998). Clearance of Pneumocystis carinii cysts in acute P carinii pneumonia - Assessment by serial sputum induction. CHEST, 114(5), 1264-1268.

Effects of estrogen replacement therapy on the lipoprotein profile in postmenopausal women with ESRD
Ginsburg, E. S., Walsh, B., Greenberg, L., Price, D., Chertow, G. M., & Owen, W. F. (1998). Effects of estrogen replacement therapy on the lipoprotein profile in postmenopausal women with ESRD. KIDNEY INTERNATIONAL, 54(4), 1344-1350.

Cancer screening and detection in patients with end-stage renal disease
Gornik, H. L., Lazarus, J. M., & Chertow, G. M. (1998). Cancer screening and detection in patients with end-stage renal disease. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 21(9), 495-500.

Haemobilia mimicking acute cholecystitis following percutaneous renal biopsy
Lee, M. C., Jacobs, D. O., & Chertow, G. M. (1998). Haemobilia mimicking acute cholecystitis following percutaneous renal biopsy. NEPHROLOGY DIALYSIS TRANSPLANTATION, 13(8), 2118-2120.

beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts
Owen, W. F., Hou, F. F., Stuart, R. O., Kay, J., Boyce, J., & Schimidt, A. M. (1998). beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts. KIDNEY INTERNATIONAL, 53(5), 1365-1373.

Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis
Chertow, G. M., Lazarus, J. M., Paganini, E. P., Allgren, R. L., Lafayette, R. A., & Sayegh, M. H. (1998). Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 9(4), 692-698.

Independent association between acute renal failure and mortality following cardiac surgery
Chertow, G. M., Levy, E. M., Hammermeister, K. E., Grover, F., & Daley, J. (1998). Independent association between acute renal failure and mortality following cardiac surgery. AMERICAN JOURNAL OF MEDICINE, 104(4), 343-348.

Olecranon bursitis caused by infection with Candida lusitaniae
Behar, S. M., & Chertow, G. H. (1998). Olecranon bursitis caused by infection with Candida lusitaniae. JOURNAL OF RHEUMATOLOGY, 25(3), 598-600.

Dialysis: Cost-effective "SUPPORT" for patients with acute renal failure
Chertow, G. M. (1998). Dialysis: Cost-effective "SUPPORT" for patients with acute renal failure. AMERICAN JOURNAL OF KIDNEY DISEASES, 31(3), 545-548.

Aminoguanidine inhibits advanced glycation end products formation on beta 2-microglobulin
Hou, F. F., Boyce, J., Chertow, G. M., Kay, J., & Owen, W. F. (1998). Aminoguanidine inhibits advanced glycation end products formation on beta 2-microglobulin. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 9(2), 277-283.

Bioimpedance norms for the hemodialysis population
Chertow, G. M., Lazarus, J. M., Lew, N. L., Ma, L. H., & Lowrie, E. G. (1997). Bioimpedance norms for the hemodialysis population. KIDNEY INTERNATIONAL, 52(6), 1617-1621.

Antigen-independent determinants of graft survival in living-related kidney transplantation
Chertow, G. M., BRENNER, B. M., Mori, M., Mackenzie, H. S., & Milford, E. L. (1997). Antigen-independent determinants of graft survival in living-related kidney transplantation. KIDNEY INTERNATIONAL, S84-S86.

On the design and analysis of multicenter trials in acute renal failure
Chertow, G. M. (1997). On the design and analysis of multicenter trials in acute renal failure. AMERICAN JOURNAL OF KIDNEY DISEASES, 30(5), S96-S101.

Renal vasculitis with HIV seropositivity: Potential manifestation of cytomegalovirus infection
Chertow, G. M., Rennke, H. G., Curhan, G. C., & Brady, H. R. (1997). Renal vasculitis with HIV seropositivity: Potential manifestation of cytomegalovirus infection. AMERICAN JOURNAL OF KIDNEY DISEASES, 30(3), 428-432.

The rise and fall of atrial natriuretic peptide for acute renal failure
Brenner, R. M., & Chertow, G. M. (1997). The rise and fall of atrial natriuretic peptide for acute renal failure. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 6(5), 474-476.

Nephrology
Chertow, G. M. (1997). Nephrology. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 277(23), 1872-1873.

Development of a population-specific regression equation to estimate total body water in hemodialysis patients
Chertow, G. M., Lazarus, J. M., Lew, N. L., Ma, L. H., & Lowrie, E. G. (1997). Development of a population-specific regression equation to estimate total body water in hemodialysis patients. KIDNEY INTERNATIONAL, 51(5), 1578-1582.

Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related amyloidosis
Hou, F. F., Chertow, G. M., Kay, J., Boyce, J., Lazarus, J. M., & Owen, W. F. (1997). Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related amyloidosis. KIDNEY INTERNATIONAL, 51(5), 1514-1519.

A practical approach to acute renal failure
Mindell, J. A., & Chertow, G. M. (1997). A practical approach to acute renal failure. MEDICAL CLINICS OF NORTH AMERICA, 81(3), 731-?.

Preoperative renal risk stratification
Chertow, G. M., Lazarus, J. M., Christiansen, C. L., Cook, E. F., Hammermeister, K. E., & Daley, J. (1997). Preoperative renal risk stratification. CIRCULATION, 95(4), 878-884.

Poorer graft survival in African-American transplant recipients cannot be explained by HLA mismatching.
Chertow, G. M., & Milford, E. L. (1997). Poorer graft survival in African-American transplant recipients cannot be explained by HLA mismatching. Advances in renal replacement therapy, 4(1), 40-45.

Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure
Chertow, G. M., Burke, S. K., Lazarus, J. M., Stenzel, K. H., Wombolt, D., & Slatopolsky, E. (1997). Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. AMERICAN JOURNAL OF KIDNEY DISEASES, 29(1), 66-71.

Antigen-independent determinants of cadaveric kidney transplant failure
Chertow, G. M., Milford, E. L., Mackenzie, H. S., & BRENNER, B. M. (1996). Antigen-independent determinants of cadaveric kidney transplant failure. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 276(21), 1732-1736.

Grafts vs fistulas for hemodialysis patients - Equal access for all?
Chertow, G. M. (1996). Grafts vs fistulas for hemodialysis patients - Equal access for all?. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 276(16), 1343-1344.

Fanconi's syndrome and tubulointerstitial nephritis in association with L-lysine ingestion
Lo, J. C., Chertow, G. M., Rennke, H., & Seifter, J. L. (1996). Fanconi's syndrome and tubulointerstitial nephritis in association with L-lysine ingestion. AMERICAN JOURNAL OF KIDNEY DISEASES, 28(4), 614-617.

Birth weight and adult hypertension and obesity in women
Curhan, G. C., Chertow, G. M., Willett, W. C., Spiegelman, D., Colditz, G. A., & Stampfer, M. J. (1996). Birth weight and adult hypertension and obesity in women. CIRCULATION, 94(6), 1310-1315.

Restless legs syndrome in end-stage renal disease
Winkelman, J. W., Chertow, G. M., & Lazarus, J. M. (1996). Restless legs syndrome in end-stage renal disease. AMERICAN JOURNAL OF KIDNEY DISEASES, 28(3), 372-378.

Trimethoprim-sulfamethoxazole and hypouricemia
Chertow, G. M., Seifter, J. L., Christiansen, C. L., & ODONNELL, W. J. (1996). Trimethoprim-sulfamethoxazole and hypouricemia. CLINICAL NEPHROLOGY, 46(3), 193-198.

Performance characteristics of a dialysis-related amyloidosis questionnaire
Chertow, G. M., TRIMBUR, T., Karlson, E. W., Lazarus, J. M., & Kay, J. (1996). Performance characteristics of a dialysis-related amyloidosis questionnaire. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(8), 1235-1240.

''Renal-dose'' dopamine for the treatment of acute renal failure: Scientific rationale, experimental studies and clinical trials
Denton, M. D., Chertow, G. M., & Brady, H. R. (1996). ''Renal-dose'' dopamine for the treatment of acute renal failure: Scientific rationale, experimental studies and clinical trials. KIDNEY INTERNATIONAL, 50(1), 4-14.

Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure?
Chertow, G. M., Sayegh, M. H., Allgren, R. L., & Lazarus, J. M. (1996). Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure?. AMERICAN JOURNAL OF MEDICINE, 101(1), 49-53.